Related Experiment Video
Updated: Dec 29, 2025

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
How Complementary Targets Expose the microRNA 3' End for Tailing and Trimming during Target-Directed microRNA
Paulina Pawlica1, Jessica Sheu-Gruttadauria2, Ian J MacRae2
1Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06536, USA.
Abstract:
microRNAs (miRNAs) are crucial for posttranscriptional regulation of messenger RNAs. "Classical" miRNA targets predominantly interact with the miRNA seed sequence located near the miRNA 5' end. Interestingly, certain transcripts that exhibit extensive complementarity to the miRNAs 3' region, instead of being subjected to regulation, induce miRNA decay in a process termed target-directed miRNA degradation (TDMD). Here, we review recent advances in understanding the molecular mechanisms of TDMD. Specifically, we discuss how extensive miRNA complementarity to TDMD-inducing targets results in displacement of the miRNA 3' end from its protective pocket in the Argonaute protein. Unprotected miRNA 3' ends are then available for enzymatic attack by still-unidentified cellular enzymes. Identification of these cellular enzymes and discovery of additional TDMD-inducing transcripts are subjects for future research.
Insights
Target-directed miRNA degradation (TDMD) is a process where specific transcripts trigger the breakdown of microRNAs (miRNAs). This occurs when extensive complementarity to the miRNA 3' end exposes it to cellular enzymes.
Area of Science:
- Molecular Biology
- Gene Regulation
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression at the posttranscriptional level.
- Canonical miRNA function involves seed sequence binding, leading to gene silencing.
- An alternative pathway, target-directed miRNA degradation (TDMD), involves extensive 3 e region complementarity.
Purpose of the Study:
- To review recent advancements in understanding the molecular mechanisms of target-directed miRNA degradation (TDMD).
- To elucidate how extensive miRNA complementarity to specific targets triggers miRNA decay.
Main Methods:
- Review of current literature on miRNA-mediated gene regulation and TDMD.
- Analysis of molecular interactions between miRNAs and their targets in the context of TDMD.
- Discussion of the structural changes in Argonaute protein-miRNA complexes during TDMD.
Main Results:
- Extensive complementarity between miRNAs and TDMD-inducing targets destabilizes the miRNA-Argonaute complex.
- The 3 e end of the miRNA becomes unprotected and accessible for enzymatic degradation.
- This process leads to the decay of the miRNA, rather than target repression.
Conclusions:
- TDMD represents a distinct mechanism of miRNA regulation driven by specific target interactions.
- The unprotected 3 e end of the miRNA is a critical feature enabling its degradation.
- Future research should focus on identifying the cellular enzymes responsible for miRNA decay in TDMD and discovering novel TDMD-inducing transcripts.
More Related Videos
07:19Identifying Targets of Human microRNAs with the LightSwitch Luciferase Assay System using 3'UTR-reporter Constructs and a microRNA Mimic in Adherent Cells
Published on: September 28, 2011
12:49Detection of miRNA Targets in High-throughput Using the 3'LIFE Assay
Published on: May 25, 2015
Related Concept Videos
MicroRNAs
MicroRNAs
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi